---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-025334"
form_type: "8-K"
ticker: "OWLT"
cik: "0001816708"
company_name: "Owlet, Inc."
filed_at: "2023-07-21T23:59:59+00:00"
generated_at: "2026-06-13T05:04:34.489203+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Owlet appoints Melissa Gonzales to board; brings women's health and consumer healthcare expertise

## Summary
- Melissa Gonzales appointed as Class I director effective July 18, 2023, term expiring at 2025 annual meeting.
- Gonzales is President, Women's Health at Myriad Genetics (MYGN) and brings 20+ years healthcare experience.
- She will receive annual cash retainer of $50k and initial RSU grant valued ~$150k prorated.
- Owlet CEO cites Gonzales' expertise as key as company prepares to launch BabySat FDA-cleared pulse oximetry device.
- Gonzales also serves as Board Chair of March of Dimes, Chicago.

## SEC filing metadata
- accession: 0001628280-23-025334
- form_type: 8-K
- ticker: OWLT
- cik: 0001816708
- company_name: Owlet, Inc.
- filed_at: 2023-07-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/0001628280-23-025334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/owlt-20230718.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-025334
- JSON: https://secwatch.observer/filing/0001628280-23-025334.json
- Plain text: https://secwatch.observer/filing/0001628280-23-025334.txt

## Key facts
- Executive change
  Melissa Gonzales was appointed as Class I director at Owlet, Inc..
  - Action: appointed
  - Role: Class I director
  source text: appointed Melissa Gonzales to serve as a Class I director of the Board, effective July 18, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/0001628280-23-025334-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.